Acceleron Pharma Inc
XLRNDelisted Nov 22, 2021- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001280600
Acceleron Pharma Inc was delisted on Nov 22, 2021; its insiders filed their last Form 4 on Nov 22, 2021; 333 institutions reported holding it in 13F filings for Q3 2021, worth $9.22B in total; no superinvestor held it.
13F holders, Q1 2024
Institutional positions in Acceleron Pharma Inc as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
XLRN is no longer listed, and 13F filings after Q3 2021 list far fewer holders. See Q3 2021
- Institutional holders
- 1
- 0 vs. Q4 2023
- Shares held
- 2
- 0 (0.0%) vs. Q4 2023
- Total value
- $358
- $0 (0.0%) vs. Q4 2023
- New holders
- 0
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting XLRN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $358 |
| Q1 2026 | 1 | $358 |
| Q4 2025 | 1 | $358 |
| Q3 2025 | 1 | $358 |
| Q2 2025 | 1 | $358 |
| Q1 2025 | 1 | $358 |
| Q4 2024 | 1 | $358 |
| Q3 2024 | 1 | $358 |
| Q2 2024 | 1 | $358 |
| Q1 2024 | 1 | $358 |
| Q4 2023 | 1 | $358 |
| Q3 2023 | 1 | $358 |
| Q2 2023 | 1 | $358 |
| Q1 2023 | 1 | $358 |
| Q4 2022 | 1 | $358 |
| Q3 2022 | 1 | $0 |
| Q2 2022 | 1 | $0 |
| Q1 2022 | 1 | $0 |
| Q4 2021 | 1 | $0 |
| Q3 2021 | 333 | $9.22B |
| Q2 2021 | 271 | $6.78B |
| Q1 2021 | 256 | $7.30B |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Acceleron Pharma Inc; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Huntington National Bank | 2 | $358 | 0.00% | 00.0% | Unchanged |